The accompanying AAT plasma deficiency leaves the lungs exposed to neutrophil elastase, resulting in premature emphysema [7], which can be relieved by IV infusion of human plasma-derived AAT [8]. The gene discussed is SERPINA1; the disease is pulmonary emphysema.